Brief: Xwell's US GAAP Misapplication Related To Impairment Of Treat Inc Business Segment Ended Sept 30, 2023
12/04/2024 22:31
April 12 (Reuters) - XWELL Inc XWEL.O :
* XWELL:MISAPPLICATION OF U.S. GAAP AS RELATED TO
DETERMINATION OF
IMPAIRMENT OF CO'S TREAT, INC. BUSINESS SEGMENT FOR 3 & 9 MONTHS
ENDED SEPT 30, 2023
Source text for Eikon: ID:n0001104659-24-046834
Further company coverage: XWEL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on XWELL
See all newsMedia: Trump family-linked American Ventures backs XWell, a spa company offering medical screening- FT
Brief: Xwell Registers Resale Of Up To 138.7 Million Shares Of Common Stock From Time To Time By Selling Stockholders - SEC Filing
NASDAQ RESUMED AT 10:15 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:09 AM
NASDAQ RESUMED AT 09:57 AM